Biotech

VGI Health Technology Limited (NSX:VTL) Study Protocol Approved

🕔9/13/2021 9:39:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it's operational subsidiary, Invictus Ops Pty Ltd., has approved a clinical study protocol for a clinical study to be conducted by Altipure R&D in Ohio.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Meet the CEO Investor Webinar

🕔9/7/2021 10:44:18 AM

Anatara Lifesciences (ASX:ANR), a developer of evidence based solutions for gastrointestinal health in humans and animals, invites shareholders to attend a virtual group briefing with Chief Executive Officer, Steven Lydeamore, on Thursday 9 September 2021 at 11:00am AEST.

Read Full Article

VGI Health Technology Limited (NSX:VTL) Renewal of Research and Development Receivable Facility

🕔9/7/2021 9:12:00 AM

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has agreed with FIFO Capital to renew a Receivable Finance Facility with respect to VTL's assessed tax cash benefit under the Federal Government's R&D Tax Incentive Program.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Investor Presentation

🕔9/6/2021 9:36:59 AM

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.

Read Full Article

BTC Health Limited (ASX:BTC) Shareholder Update - September 2021

🕔9/3/2021 9:23:17 AM

I am pleased to provide you with a detailed update on BTC Health Limited's (ASX:BTC) investments, along with an operational update of BTC's wholly owned investee companies.

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Launches IBS-D Clinical Trial Recruitment Website

🕔8/20/2021 8:13:43 AM

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to announce the launch of its IBS-D Clinical Trial recruitment website.

Read Full Article

BTC Health Limited (ASX:BTC) Annual Report - 30 June 2021

🕔8/17/2021 5:24:28 PM

The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.

Read Full Article